Patents by Inventor Yi ZHEN

Yi ZHEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11488814
    Abstract: In an embodiment, a magnetic assembly includes: an inner permeance annulus; and an outer permeance annulus connected to the inner permeance annulus via magnets, wherein the outer permeance annulus comprises a peak region with a thickness greater than other regions of the outer permeance annulus.
    Type: Grant
    Filed: October 8, 2019
    Date of Patent: November 1, 2022
    Assignee: Taiwan Semiconductor Manufacturing Co., Ltd.
    Inventors: Tsung-Jen Yang, Yi-Zhen Chen, Chih-Pin Wang, Chao-Li Shih, Ching-Hou Su, Cheng-Yi Huang
  • Publication number: 20220119701
    Abstract: Water-soluble, fluorescent particles and compositions, kits, and methods of making and using such particles are disclosed. Processes for preparing fluorescent particles and for controlling the size, polydispersity and optical properties of such particles also are provided.
    Type: Application
    Filed: October 29, 2021
    Publication date: April 21, 2022
    Inventors: Adam YORK, Eric WELCH, Kyle GEE, Xin WANG, Robert AGGELER, Yi-Zhen HU
  • Publication number: 20210386695
    Abstract: The present disclosure relates to a method for inhibiting a binding of a SARS-CoV-2 spike protein of a SARS-CoV-2 to an angiotensin-converting enzyme 2 including contacting the SARS-CoV-2 with a sufficient concentration of disulfiram, a method for inhibiting an activity of a main protease (Mpro) of SARS-CoV-2 including contacting a SARS-CoV-2 with a sufficient concentration of disulfiram, and a method for inhibiting an activity of a papain-like protease (PLpro) of SARS-CoV-2 including contacting a SARS-CoV-2 with a sufficient concentration of disulfiram. A method for inhibiting a replication or an infection of a SARS-CoV-2 in a cell includes contacting the cell with a sufficient concentration of disulfiram and a medical composition for use in a treatment of an infection of SARS-CoV-2 including a therapeutically effective amount of disulfiram are also provided.
    Type: Application
    Filed: June 16, 2021
    Publication date: December 16, 2021
    Applicant: China Medical University
    Inventors: Chang-Hai Tsai, Mien-chie Hung, Yeh Chen, Wen-Hao Yang, Chia-shin Yang, Yu-Lin Hung, Yu-Chuan Wang, Yi-Zhen Chou, Mei-Hui Hou, Chia-Ling Tsai, Bao-Yue Huang, Chian-Fang Hung, Hsiao-Fan Chen, Wen-Chi Su, Wei-Jan Wang
  • Patent number: 11194860
    Abstract: Systems and methods are disclosed for question generation to obtain more related medical information based on observed symptoms from a patient. In embodiments, possible diseases associated with the observed symptoms are generated by querying a knowledge graph. In embodiments, candidate symptoms associated with the possible diseases are also identified and are combined with the observed symptoms to obtain combined symptom sets. In embodiments, discriminative scores for the candidate symptom sets are determined and candidate symptoms with top discriminative scores are selected. In embodiments, these selected candidate symptoms may be checked for conflicts with observed symptoms and removed from further consideration if a conflict exists. In embodiments, one or more questions may be generated based on the remaining selected candidate systems to aid in collecting information about the patient. In embodiments, the process may be repeated with the updated observed symptoms.
    Type: Grant
    Filed: July 11, 2016
    Date of Patent: December 7, 2021
    Assignee: Baidu USA LLC
    Inventors: Erheng Zhong, Chaochun Liu, Yusheng Xie, Nan Du, Hongliang Fei, Yi Zhen, Yu Cao, Richard Chun Ching Wang, Dawen Zhou, Wei Fan
  • Patent number: 11195128
    Abstract: Presented are systems and methods that allow healthcare providers and governments to infer demand for healthcare resources to ensure effective and timely healthcare services to patients by reducing healthcare supply shortages, emergencies, and healthcare costs. In embodiments, this is accomplished by gathering data from a number of sources to generate labeled records from which entity features and relationships between entities are extracted, correlates, and/or combined with other external healthcare data. In embodiments, this information is used to train a model that predicts healthcare resource demands given a set of input conditions or factors.
    Type: Grant
    Filed: August 2, 2016
    Date of Patent: December 7, 2021
    Assignee: Baidu USA LLC
    Inventors: Yi Zhen, Hongliang Fei, Shulong Tan, Wei Fan
  • Patent number: 11193057
    Abstract: Water-soluble, fluorescent particles and compositions, kits, and methods of making and using such particles are disclosed. Processes for preparing fluorescent particles and for controlling the size, polydispersity and optical properties of such particles also are provided.
    Type: Grant
    Filed: August 24, 2017
    Date of Patent: December 7, 2021
    Assignee: Life Technologies Corporation
    Inventors: Adam York, Eric Welch, Kyle Gee, Xin Wang, Robert Aggeler, Yi-Zhen Hu
  • Publication number: 20210330661
    Abstract: The present disclosure relates to a method for preventing or inhibiting a synthesis of viral RNA of SARS-CoV-2 in a cell including contacting the cell with a sufficient concentration of tafenoquine, boceprevir or narlaprevir and a method for inhibiting an activity of a main protease (Mpro) of SARS-CoV-2 including contacting a SARS-CoV-2 with a sufficient concentration of tafenoquine, boceprevir or narlaprevir. A medical composition for use in a treatment of an infection of SARS-CoV-2 including a therapeutically effective amount of tafenoquine, boceprevir or narlaprevir is also provided.
    Type: Application
    Filed: April 22, 2021
    Publication date: October 28, 2021
    Applicant: China Medical University
    Inventors: Mien-Chie Hung, Yeh Chen, Wen-Hao Yang, Chia-Shin Yang, Yu-Lin Hung, Yu-Quan Wang, Yi-Zhen Chou, Mei-Hui Hou, Chia-Ling Tsai, Bao-Yue Huang, Chian-Fang Hung
  • Publication number: 20210326526
    Abstract: Various embodiments relate to a method and non-transitory computer readable medium for genome spelling correction, the method including the steps of performing pre-processing on a sentence, storing a first adjacent word to an unknown word and a second adjacent word to the unknown word, generating a plurality of candidate words for the unknown word, forming a plurality of trigrams with the first adjacent word to the unknown word and the second adjacent word to the unknown word and each of the plurality of candidate words, searching a trigram table for each of the plurality of trigrams and outputting the candidate word from the trigram with a highest trigram count in the trigram table.
    Type: Application
    Filed: June 20, 2019
    Publication date: October 21, 2021
    Inventors: Charles Yee, Samuel Frank Pilato, Joseph Qin, Yi Zhen
  • Publication number: 20210324198
    Abstract: Silicon-substituted rhodamine compounds are disclosed herein. Also described herein are SiR dyes comprising at least one vinyl group attached to the Si atom (10 position) of the SiR dye. Derivatives, functionalized versions, conjugates, kits, related synthetic methods and uses of SiR compounds also are provided. Silicon-rhodamine (SiR) dyes can provide bright fluorescence at far red wavelengths and exhibit good photostability. The compounds described herein can be useful for fluorescent labeling and detection of biological samples.
    Type: Application
    Filed: August 8, 2019
    Publication date: October 21, 2021
    Inventors: Jongtae YANG, Xin WANG, Yi-Zhen HU, Kyle GEE, Aimei CHEN, Scott BENSON, Brian EVANS, Aleksey RUKAVISHNIKOV
  • Publication number: 20210198442
    Abstract: A method of forming foam material is provided, which includes mixing 100 parts by weight of a compound having cyclic carbonate groups and a foaming agent to form a foaming composition, wherein the foaming agent includes 3 to 13 parts by weight of carbamate salt and 15 to 65 parts by weight of amino compound. The foaming composition is heated to 100° C. to 170° C. for decomposing the carbamate salt into CO2 and amino compound, and the amino compound is reacted with the compound having cyclic carbonate groups to form the foam material.
    Type: Application
    Filed: December 31, 2019
    Publication date: July 1, 2021
    Applicant: INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE
    Inventors: Mao-Lin HSUEH, Yi-Zhen CHEN, Chih-Kuang CHANG
  • Patent number: 10983856
    Abstract: The disclosed embodiments provide a system for identifying root causes of performance issues. During operation, the system obtains a call graph containing a set of call paths for a set of services. Next, the system determines, based on a load test of the set of services, severity scores for the set of services, wherein the severity scores represent levels of abnormal behavior in the set of services. The system then groups the severity scores by the set of call paths and identifies, based on the grouped severity scores, one or more services as potential root causes of performance issues in the set of services. Finally, the system outputs the identified one or more services as the potential root causes of the performance issues.
    Type: Grant
    Filed: June 28, 2019
    Date of Patent: April 20, 2021
    Assignee: Microsoft Technology Licensing, LLC
    Inventors: Yi Zhen, Yung-Yu Chung, Yang Yang, Bo Long
  • Patent number: 10973748
    Abstract: The composition includes a cyclic, unsaturated compound, preferably a polyphenol derivative. It reduces the synthesis of melanin by inhibiting the activity and expression levels of tyrosinase and related proteins, thereby preventing and limiting the content and distribution of melanin in mammalian skin. It also induces autophagy of melanosome, thereby restricting the synthesis, storage and transfer of melanin from melanocyte to keratinocyte. The dual modes of action allow for the efficacy of the composition at low dosage without causing toxicity to lighten skin and treat disorders associated with hyperpigmentation.
    Type: Grant
    Filed: April 21, 2016
    Date of Patent: April 13, 2021
    Assignee: VERSITECH LIMITED
    Inventors: Mingfu Wang, Shu Ting Hu, Yi Zhen Wu
  • Patent number: 10959611
    Abstract: The present disclosure relates to a visual field testing method, system, and testing apparatus based on head-mounted testing equipment. The method includes: transmitting, by the testing apparatus in electronic equipment, a start notification for starting monitoring of a movement trajectory of a pupil of a current eye to be tested to an eye movement tracking system after receiving a start test instruction transmitted from a controller; receiving, by the testing apparatus, movement state information of the pupil that is transmitted from the eye movement tracking system; and determining, by the testing apparatus, the movement trajectory of the pupil according to the movement state information, wherein the controller is a component that is associated with the head-mounted testing equipment and communicatively connected to the testing apparatus of the electronic equipment.
    Type: Grant
    Filed: June 1, 2018
    Date of Patent: March 30, 2021
    Assignee: ZHUHAI WIIFINE MEDINFORMATION TECHNOLOGY CO., LTD.
    Inventors: Yi Zhen, Weihong Zheng, Cong Zhang
  • Publication number: 20200409781
    Abstract: The disclosed embodiments provide a system for identifying root causes of performance issues. During operation, the system obtains a call graph containing a set of call paths for a set of services. Next, the system determines, based on a load test of the set of services, severity scores for the set of services, wherein the severity scores represent levels of abnormal behavior in the set of services. The system then groups the severity scores by the set of call paths and identifies, based on the grouped severity scores, one or more services as potential root causes of performance issues in the set of services. Finally, the system outputs the identified one or more services as the potential root causes of the performance issues.
    Type: Application
    Filed: June 28, 2019
    Publication date: December 31, 2020
    Inventors: Yi Zhen, Yung-Yu Chung, Yang Yang, Bo Long
  • Publication number: 20200329962
    Abstract: Retina digital imaging system, instrument and method A retina digital imaging system includes: an illumination module (1), a main optical assembly (3), and an image sensor module (2); the illumination module (1) includes light-emitting diodes capable of emitting light with different wavelengths, and each light-emitting diode emits light to enter the retina through the main optical assembly (3) to form an illumination optical path; the light reflected by the retina passes through the main optical assembly (3) and forms an image on the image sensor module (2) to form an imaging optical path. The various spectral bands formed by light-emitting diodes may form a wider spectrum, so different layers of the retina may be imaged to provide valuable medical and diagnostic data.
    Type: Application
    Filed: December 24, 2018
    Publication date: October 22, 2020
    Inventors: Ningli Wang, Yequan Huang, Jinsong Zhang, Jianwei Ren, Chao Ma, Zhenhua Chen, Xuechuan Dong, Yi Zhen, Kexing Liu, Zeljko Ribaric
  • Patent number: 10731034
    Abstract: A polyurethane urea composition and a preparation method thereof are provided. The method includes mixing and reacting an urea and an amine compound to obtain a polyurea oligomer, and mixing and reacting the polyurea oligomer and a cyclic carbonate compound to obtain a polyurethane urea composition having a repeating unit represented by formula I: —R2—U2—U1—U2—R2—, wherein ??[formula I] U1 is a is an integer of 1 to 10000, each U2 is independently each R1 is independently a C1 to C20 alkylene group, a C3 to C20 cycloalkylene group, a C8 to C20 alkylarylene group, a polyether group having a weight-average molecular weight of 100 g/mol to 10000 g/mol, or a combination thereof, and each R2 is independently an aliphatic group, a cycloaliphatic group, an aromatic group substituted by an alkyl or an unsubstituted aromatic group, an oligo polyether group, an oligo polyester group, or a combination thereof.
    Type: Grant
    Filed: March 27, 2018
    Date of Patent: August 4, 2020
    Assignee: Industrial Technology Research Institute
    Inventors: Mao-Lin Hsueh, Yi-Zhen Chen, Hsiao-Chun Yeh, Yung-Chan Lin, Cheng-Han Hsieh
  • Publication number: 20200214552
    Abstract: The present disclosure relates to a visual field testing method, system, and testing apparatus based on head-mounted testing equipment (02). The method includes: transmitting, by the testing apparatus in electronic equipment (01), a start notification for starting monitoring of a movement trajectory of a pupil of a current eye to be tested to an eye movement tracking system (03) after receiving a start test instruction transmitted from a controller; receiving, by the testing apparatus, movement state information of the pupil (202) that is transmitted from the eye movement tracking system (03); and determining, by the testing apparatus, the movement trajectory (203) of the pupil according to the movement state information, wherein the controller is a component that is associated with the head-mounted testing equipment (02) and communicatively connected to the testing apparatus of the electronic equipment (01). The method can reduce the testing complexity and may also improve the testing accuracy and comfort.
    Type: Application
    Filed: June 1, 2018
    Publication date: July 9, 2020
    Inventors: Yi Zhen, Weihong Zheng, Cong Zhang
  • Publication number: 20200161108
    Abstract: In an embodiment, a magnetic assembly includes: an inner permeance annulus; and an outer permeance annulus connected to the inner permeance annulus via magnets, wherein the outer permeance annulus comprises a peak region with a thickness greater than other regions of the outer permeance annulus.
    Type: Application
    Filed: October 8, 2019
    Publication date: May 21, 2020
    Inventors: Tsung-Jen YANG, Yi-Zhen CHEN, Chih-Pin WANG, Chao-Li SHIH, Ching-Hou SU, Cheng-Yi HUANG
  • Patent number: 10570250
    Abstract: Water-soluble, conjugated polymers containing one or more dibenzosilole monomer residues, as well as compositions, kits, and methods of making and using such polymers are disclosed. Also disclosed are dibenzosilole derivatives substituted with one or more water-solubilizing groups, and methods of making and using such derivatives to prepare water-soluble dibenzosilole polymers.
    Type: Grant
    Filed: August 21, 2018
    Date of Patent: February 25, 2020
    Assignee: LIFE TECHNOLOGIES CORPORATION
    Inventors: Kyle Gee, Xin Wang, Hee Chol Kang, Aimei Chen, Yexin Wu, Yi-Zhen Hu, Robert Aggeler, Quentin Low
  • Patent number: 10423821
    Abstract: Disclosed are systems, methods, and non-transitory computer-readable media for automated profile image generation based on scheduled video conferences. A profile image generation system generates, based on image data captured during a first video conference, a first facial feature data set for a first identified face identified from the image data. The first facial feature data set includes numeric values representing the first identified face. The profile image generation system calculates, based on the first facial feature data set and historic facial feature data sets generated from image data captured during previous video conferences, a first value indicating a likelihood that the first identified face is a first meeting participant that participated in the first video conference. The profile image generation system determines that the first value meets or exceeds a threshold value, and in response, determines that the first identified face is the first meeting participant.
    Type: Grant
    Filed: October 25, 2017
    Date of Patent: September 24, 2019
    Assignee: Microsoft Technology Licensing, LLC
    Inventors: Florian Raudies, Yi Zhen, Ajith Muralidharan, Yiming Ma